Overview

Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
This study is examining whether Vinblastine is an effective drug to shrink low grade glioma brain tumors in children, and what the side effects are.
Phase:
Phase 2
Details
Lead Sponsor:
The Hospital for Sick Children
Collaborator:
Ontario Cancer Research Network
Treatments:
Vinblastine